Streptokinase plus aspirin does the trick: ISIS-3
- PMID: 1347807
Streptokinase plus aspirin does the trick: ISIS-3
Comment on
-
ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.Lancet. 1992 Mar 28;339(8796):753-70. Lancet. 1992. PMID: 1347801 Clinical Trial.
Similar articles
-
[ISIS-2--a study of patients with myocardial infarction. A combination of streptokinase and acetylsalicylic acid diminishes mortality risk, reinfarction and stroke].Lakartidningen. 1988 Aug 31;85(35):2759-64. Lakartidningen. 1988. PMID: 3047513 Clinical Trial. Swedish. No abstract available.
-
The social history of ISIS-2: trial and tribulation.Lancet. 2015 Aug 15;386(9994):e2-3. doi: 10.1016/S0140-6736(15)61504-5. Lancet. 2015. PMID: 26334163 No abstract available.
-
[Systemic thrombolysis using streptokinase. Experiences at the Civic Hospital of Lugano in the framework of the ISIS-2 study].Schweiz Med Wochenschr. 1988 Nov 19;118(46):1702-5. Schweiz Med Wochenschr. 1988. PMID: 3212423 Clinical Trial. German.
-
Acute myocardial infarction: a true medical emergency.N Z Med J. 1989 Jun 14;102(869):281-3. N Z Med J. 1989. PMID: 2499853 Review. No abstract available.
-
[Aspirin and heparin in the fibrinolytic treatment of acute myocardial infarction].Rev Esp Cardiol. 1992;45 Suppl 2:21-8. Rev Esp Cardiol. 1992. PMID: 1475505 Review. Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical